Simon Dingemans

From Food & Medicine Encyclopedia

Revision as of 00:10, 18 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Simon Dingemans is a British businessman known for his significant contributions in the field of finance and pharmaceuticals. He has held several high-profile positions in various multinational corporations, including GlaxoSmithKline (GSK) and Goldman Sachs.

Early Life and Education[edit]

Simon Dingemans was born in the United Kingdom. He attended the University of Oxford, where he studied Economics and Management.

Career[edit]

Goldman Sachs[edit]

Dingemans began his career at Goldman Sachs, a leading global investment banking, securities and investment management firm. He worked there for more than 15 years, holding various senior roles in the company's London and New York offices. His work at Goldman Sachs involved advising on mergers and acquisitions, as well as corporate finance.

GlaxoSmithKline[edit]

In 2011, Dingemans joined GlaxoSmithKline (GSK), a British multinational pharmaceutical company, as the Chief Financial Officer (CFO). During his tenure, he played a crucial role in the company's financial management and strategic planning. He was instrumental in the implementation of a three-part transaction with Novartis in 2015, which significantly reshaped GSK's business structure.

Personal Life[edit]

Dingemans is married and has two children. He is known for his philanthropic activities, particularly in the field of education.

See Also[edit]

References[edit]

<references />

Stub icon
   This article is a United Kingdom business-related biographical stub. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.